Welcome to our dedicated page for Guardian Pharmacy Services news (Ticker: GRDN), a resource for investors and traders seeking the latest updates and insights on Guardian Pharmacy Services stock.
Guardian Pharmacy Services, Inc. provides long-term care pharmacy services for residents of long-term health care facilities. The company partners with LTCFs through a locally based pharmacy model to dispense medications and deliver technology-enabled clinical and administration services intended to support drug-regimen adherence and reduce medication-administration errors.
Recurring GRDN news covers quarterly results and guidance, resident and prescription-volume trends, the effects of drug-pricing changes, healthcare conference presentations, and capital-structure activity involving Class A common stock. Company updates also reference its pharmacy network, facility relationships, and service categories across assisted living, behavioral health, group home, and other long-term care settings.
Guardian Pharmacy Services (NYSE: GRDN) has released preliminary Q4 and FY2024 results, reporting strong performance. Q4 revenue reached $338.6 million, up 20.5% year-over-year, while resident count grew 14.1% to 186,000. The growth was driven by organic expansion and acquisitions of Heartland and Freedom Pharmacy.
FY2024 revenue climbed 17.4% to $1.228 billion, though net loss was between $71.8-72.8 million, primarily due to $131.5 million in share-based compensation related to Corporate Reorganization and IPO. Q4 net income is expected between $10.1-11.1 million.
For 2025, Guardian projects revenue of $1.330-1.350 billion and Adjusted EBITDA of $97.0-101.0 million. The company's performance was boosted by increased flu and COVID-19 vaccinations in long-term care facilities.
Guardian Pharmacy Services (NYSE: GRDN), a leading long-term care pharmacy services provider, has announced its participation in the Raymond James & Associates' 46th Annual Institutional Investors Conference. The event will take place in Orlando on March 3, 2025, featuring a company presentation at 9:50am ET.
Investors and interested parties can access the live audio webcast through the company's investor relations website at https://investors.guardianpharmacy.com. A replay of the presentation will be available on the same platform and will remain accessible until Guardian's Q1 2025 earnings release.
Guardian Pharmacy Services (NYSE: GRDN) announced a strategic partnership with Freedom Pharmacy, an independent long-term care pharmacy in Randolph, New Jersey. This marks Guardian's first venture into New Jersey, expanding its Mid-Atlantic footprint. Freedom Pharmacy, founded in 2022, serves over 1,300 residents across North, Northwest and Central New Jersey.
Linda Witzal will continue as president, and all current staff will remain employed, with plans to hire additional employees as the business grows. The partnership allows Freedom to maintain its local focus while accessing Guardian's national resources, including data analytics, HR, IT, and payor relations support.
Guardian Pharmacy Services, founded in 2004, has expanded to 50 pharmacies across 37 states through organic growth, greenfield startups, and acquisitions.
Guardian Pharmacy Services (NYSE: GRDN) reported Q3 2024 financial results with revenue of $314.4 million, up 20% year-over-year, driven by organic growth and the Heartland Pharmacy acquisition. The company's resident count increased 12% to 180,000. Despite revenue growth, Guardian reported a net loss of $105.8 million, primarily due to $122.4 million in share-based compensation expenses related to Corporate Reorganization and IPO. Adjusted EBITDA grew 20% to $23.0 million. The company provided full-year 2024 guidance projecting revenue between $1.205-1.215 billion and Adjusted EBITDA of $86.5-87.0 million.
Guardian Pharmacy Services (NYSE: GRDN), a leading long-term care pharmacy services provider, has announced its participation in the Stephens Annual Investment Conference in Nashville. The event, scheduled for November 21, 2024, will feature a fireside chat at 9:00am CT.
Investors can access the live audio webcast through the company's investor relations website, with a replay available for approximately 60 days following the event.
Guardian Pharmacy Services (NYSE: GRDN), a major long-term care pharmacy services provider, has scheduled its Q3 2024 earnings release for Tuesday, November 12, 2024, after market close. The company will host a conference call at 4:30pm ET to discuss the results. The call will be accessible via webcast at investors.guardianpharmacy.com or by phone for both U.S. and international participants. A replay will be available for approximately 60 days following the call.
Guardian Pharmacy Services announced the pricing of its upsized initial public offering (IPO) of 8,000,000 shares of Class A common stock at $14.00 per share. The company has granted underwriters a 30-day option to purchase up to 1,200,000 additional shares at the public offering price, less the underwriting discount. Trading is expected to begin on the New York Stock Exchange on September 26, 2024, under the symbol "GRDN". The offering is set to close on September 27, 2024, subject to customary conditions.
Raymond James is the lead bookrunning manager and representative of the underwriters, with Stephens Inc. and Truist Securities acting as joint bookrunning managers. A registration statement on Form S-1 for the offering was declared effective by the SEC on September 25, 2024.